- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2011
- Public Summary Document (PSD) March 2011 PBAC Meeting - PDF
Imatinib – March 2011
Imatinib, tablet, 100 mg and 400 mg (as mesylate), Glivec® - March 2011
Last updated
29 June 2011